Click Product Name to review monograph.

Document Number Product Name Effective Date
160-65-01 Red Blood Cells-Leukoreduced 22JUN2016
160-65-02 Platelets 22JUN2016
160-65-03 Plasma 22JUN2017
160-65-04 Cryoprecipitate  27OCT2016
160-65-05 Albumin
160-65-06 Immune Globulin Intravenous Human 23MAR2017
160-65-07 RhIg- Rh Immune Globulin 22JUN2016
160-65-08 Subcutaneous Immune Globulin 22JUN2016
160-65-09 C1 Esterase Inhibitor 27OCT2016
160-65-10 Recombinant Factor VII (rFVIIa) – Niastase RT  28 SEP2017
160-65-11 rFVIII-Advate
160-65-12 rFVIII-Kovaltry Antihemophilic Factor Recombinant 09FEB2017
160-65-13 rFVIII-Xyntha Antihemophilic Factor Recombinant 23MAR2017
160-65-14 FXIII-Corifact 23MAR2017
160-65-15 FVIII/vWF Humate P Antihemophilic Factor/vonWillbrand Factor Complex 23MAR2017
160-65-16 FVIII/vWF Wilate Antihemophilic Factor Recombinant  27JUL2017
160-65-17 rFIX BeneFIX  Antihemophilic Factor Recombinant 26JAN2017
160-65-18 FEIBA Anti-Inhibitor Coagulant Complex 23MAR2017
160-65-19 FIX-Immunine VH
160-65-20 rFXXIII A Tretton
160-65-21 Fibrinogen Concentrate-RiaSTAP 27OCT2016
160-65-22 Prothrombin Complex Concentrates (Octaplex, Beriplex) 27OCT2016
160-65-23
160-65-24
160-65-25  Hepatitis B Immune Globulin  26OCT2017
160-65-26 Alprolix-Antihemophilic Factor Recombinant BDD-FC Protein 27OCT2016
160-65-27 Eloctate-Antihemophilic Factor Recombinant BDD-FC Protein 27OCT2016
160-65-28 rFVIII-Nuwiq 09FEB2017
160-65-29
160-65-30

DISCLAIMER: Printed versions of any document may not be the most current version. Although every effort to ensure that all information is accurate and complete, documents and policies are regularly under review and in the process of being amended and blood product information/inserts may change.  The most current version of the policy, and/or product insert/circular of information shall apply.  Users should verify that any policy is the most current policy before acting on it. Contact your facility paging for the Transfusion Medicine Hematopathologist on call if required.